Search for: "Teva Pharmaceuticals v. FDA, et al" Results 1 - 20 of 101
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
20 Feb 2013, 7:37 am by Docket Navigator
Teva Pharmaceuticals USA Inc., et. al., 1-10-cv-00805 (DED February 11, 2013, Order) (Burke, M.J.). [read post]
19 Oct 2017, 10:29 am by Eric Caligiuri
Teva Pharmaceuticals USA, Inc. et al, Case No. 2:15-cv-1455-WCB (EDTX October 16, 2017 Order), a Federal District Court recently invalidated several patents covering Allergan’s dry-eye drug Restasis. [read post]
19 Oct 2017, 10:29 am by Eric Caligiuri
Teva Pharmaceuticals USA, Inc. et al, Case No. 2:15-cv-1455-WCB (EDTX October 16, 2017 Order), a Federal District Court recently invalidated several patents covering Allergan’s dry-eye drug Restasis. [read post]
1 Aug 2011, 8:19 am
Actavis Elizabeth LLC et al, Case No. 2010-1500 in the Court of Appeals for the Federal Circuit, decided July 29, 2011. [read post]
30 Jun 2014, 10:28 am
In these "Effient" patent-defense lawsuits, Lilly et al. assert allegations of infringement of Effient. [read post]
18 Apr 2006, 8:28 am
" Dennis Crouch of Patently-O reports Teva's motion to dismiss had been denied in the King v. [read post]
31 Jan 2019, 8:32 am
TEVA Pharmaceuticals USA INC., et al.,  had the opportunity to interpret the Leahy-Smith America Invents Act (AIA) with respect to how this impacts on the issue of the novelty of an invention. [read post]
17 Mar 2020, 1:32 pm by Noble McIntyre
One Lot of Topotecan Injection 4 mg/4 mL (1 mg/mL) has been recalled by Teva Pharmaceuticals due to the presence of particulate matter. [read post]
18 Mar 2010, 2:30 am
Teva Pharmaceuticals USA, Inc. et al. and Gilead Sciences, Inc., et al. v. [read post]